A path to early diagnosis of mild cognitive impairment and dementia: validity and reliability of the myMemCheck® self-administered screening tool

Fam Pract. 2020 Sep 5;37(4):561-567. doi: 10.1093/fampra/cmaa014.

Abstract

Background: Barriers to the early detection of mild cognitive impairment (MCI) and dementia can delay diagnosis and treatment. myMemCheck® was developed as a rapid free cognitive self-assessment tool that can be completed at home to identify older adults that would benefit from a more comprehensive cognitive evaluation.

Objective: Two prospective cross-sectional studies were conducted to examine the psychometric properties and clinical utility of myMemCheck®.

Methods: In Study 1, participants were independent living residents referred to an outpatient memory clinic (N = 59); older adults in the community and post-acute nursing home residents (N = 357) comprised Study 2.

Results: Psychometric analyses were performed on cognitive and psychological testing data, including myMemCheck®. myMemCheck® evidenced adequate reliability and strong construct validity. Receiver operating characteristic analysis evidenced an optional myMemCheck® cut score for identifying older adults at risk for MCI or dementia. myMemCheck® explained 25% of cognitive status beyond basic patient information.

Conclusions: myMemCheck® may help fast-track the diagnostic process, facilitate appropriate referrals for cognitive and neuropsychological evaluation, reduce assessment burden in health care and prevent negative outcomes associated with undetected cognitive impairment.

Keywords: Community medicine; dementia; geriatrics; nursing homes; screening; self-management.

MeSH terms

  • Aged
  • Cognitive Dysfunction* / diagnosis
  • Cross-Sectional Studies
  • Dementia* / diagnosis
  • Early Diagnosis
  • Humans
  • Prospective Studies
  • Reproducibility of Results